Loading...
XNYSSENS
Market cap349mUSD
Jan 15, Last price  
0.73USD
1D
-2.17%
1Q
108.34%
Jan 2017
-72.69%
IPO
-78.23%
Name

Senseonics Holdings Inc

Chart & Performance

D1W1MN
XNYS:SENS chart
P/E
P/S
15.63
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
29.26%
Rev. gr., 5y
3.43%
Revenues
22m
+36.62%
17,000038,000332,0006,373,00018,913,00021,301,0004,949,00013,675,00016,389,00022,390,000
Net income
-60m
L
-18,779,000-18,885,000-29,877,000-43,930,000-59,101,000-93,971,000-126,234,000-191,024,000-317,781,000142,119,000-60,392,000
CFO
-70m
L+5.81%
-17,167,000-19,270,000-25,465,000-38,016,000-55,739,000-90,771,000-136,047,000-67,422,000-56,078,000-66,312,000-70,163,000
Earnings
Feb 26, 2025

Profile

Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
IPO date
Mar 04, 2015
Employees
121
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
22,390
36.62%
16,389
19.85%
Cost of revenue
68,051
53,382
Unusual Expense (Income)
NOPBT
(45,661)
(36,993)
NOPBT Margin
Operating Taxes
18,703
Tax Rate
NOPAT
(45,661)
(55,696)
Net income
(60,392)
-142.49%
142,119
-144.72%
Dividends
Dividend yield
Proceeds from repurchase of equity
7,376
31,604
BB yield
-2.28%
-4.96%
Debt
Debt current
368
15,579
Long-term debt
53,991
61,761
Deferred revenue
Other long-term liabilities
102
89,706
Net debt
(55,097)
(78,928)
Cash flow
Cash from operating activities
(70,163)
(66,312)
CAPEX
(350)
(312)
Cash from investing activities
89,713
26,882
Cash from financing activities
20,366
41,762
FCF
(53,305)
(56,793)
Balance
Cash
109,456
144,015
Long term investments
12,253
Excess cash
108,336
155,449
Stockholders' equity
(831,083)
(771,408)
Invested Capital
952,414
933,189
ROIC
ROCE
EV
Common stock shares outstanding
567,974
618,206
Price
0.57
-44.65%
1.03
-61.42%
Market cap
323,802
-49.15%
636,752
-43.53%
EV
306,361
595,480
EBITDA
(44,384)
(36,008)
EV/EBITDA
Interest
11,110
18,703
Interest/NOPBT